We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Bourke, SC, Tomlison, M, Williams, TL, Bullock, RE, Shaw, PJ, Gibson, GJ.Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol.2006;5(2):140–7.CrossRefGoogle Scholar
2
2.Jackson, CE, Rosenfeld, J, Moore, DH, Bryan, WW, Barohn, RJ, Wrench, M, et al.A preliminary evaluation of a prospective study of pulmonary funcion studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci.2001;191:75–8.Google Scholar
3
3.Bourke, SC, Bullock, RE, Williams, TL, Shaw, PJ, Gibson, GJ.Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology.2003;61:171–7.Google Scholar
4
4.Lyall, RA, Donaldson, N, Fleming, T, Wood, C, Newson-Davis, I, Polkey, MI, et al.A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology.2001;57:153–6.CrossRefGoogle ScholarPubMed
5
5.Miller, RG, Jackson, CE, Kasarskis, EJ, England, JD, Forshew, D, Johnston, W, et al.Practice parameters update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review). Neurology.2009;73:1218–26.CrossRefGoogle ScholarPubMed
6
6.Ritsma, BR, Berger, MJ, Charland, DA, Khoury, MA, Phillips, JT, Quon, MJ, et al.NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. Can J Neurol Sci.2010;37:54–60.Google Scholar